# Study Aiming to Compare the Plasma Exposure of the Payload (Free-DXd) in Patients Treated by T-DXd for Locally Advanced or Metastatic Breast Cancer According to Their BMI.

> **NCT07195344** · PHASE4 · RECRUITING · sponsor: **Institut Claudius Regaud** · enrollment: 210 (estimated)

## Conditions studied

- Locally Advanced or Metastatic Breast Cancers

## Interventions

- **BIOLOGICAL:** Pharmacokinetics blood samples

## Key facts

- **NCT ID:** NCT07195344
- **Lead sponsor:** Institut Claudius Regaud
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-15
- **Primary completion:** 2029-10
- **Final completion:** 2029-10
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07195344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07195344, "Study Aiming to Compare the Plasma Exposure of the Payload (Free-DXd) in Patients Treated by T-DXd for Locally Advanced or Metastatic Breast Cancer According to Their BMI.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07195344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*